SecBot SecBot
Insider Cluster (4 insiders) ·Filed Aug 10, 2026

ATTO

Attovia Therapeutics, Inc.
BULLISH
Impact 8/10
Horizondays Processed2mo ago
Insider cluster: 4 insiders, $25.0M total
Actionable Insight ▲ Bullish

This concentrated buying from top-tier healthcare investors (including Sanofi) is a powerful endorsement. Monitor for upcoming clinical data or partnership announcements that may have motivated the cluster. The $17 entry price provides a potential floor for near-term support.

DirectionBullish
Confidencehigh
Horizondays
Latest settled — T+20d
ATTO ▲ +22.57% at T+20d
LONG call ✓ call won +22.57% · α vs SPY +23.63% · entry $18.65 → $22.86
Next anchor: T+60d in 7d
Entry = T+0 close
Aug 10, 2026
via day close
T+1d
-3.16%
call -3.16% · α -3.41%
$18.06
settled 3mo ago
T+5d
+24.61%
call +24.61% · α +25.01%
$23.24
settled 2mo ago
T+20d
+22.57%
call +22.57% · α +23.63%
$22.86
settled 7w ago
T+60d
Pending
in 7d

Price Chart

Loading chart...

Executive Summary

Four major 10% owners (Sanofi, Redmile, venBio, Frazier Life Sciences) collectively purchased $25M in open-market shares of ATTO at $17/share on August 6, 2026, representing 2.72% of the $919M market cap. This is a highly material cluster of insider buying from sophisticated healthcare investors, signaling strong conviction in the company's prospects.

Key Financial Metrics

Direction
buying
Total Value
$25.0M
Insiders
4

Key Facts

  • Four 10% owners (Sanofi, Redmile, venBio, Frazier Life Sciences) made open-market purchases totaling $25M on August 6, 2026
  • All purchases executed at $17.00 per share
  • Total open-market purchases represent 2.72% of ATTO's $919M market cap
  • Concurrent derivative conversions (non-cash) by the same holders added ~60M shares via conversion of prior securities
  • No C-suite or board insider participated in the buying

Financial Impact

$25M in open-market purchases from four major holders, representing 2.72% of market cap

ownership concentrationmarket confidence

Risk Factors

  • No C-suite insider participation reduces the signal strength relative to a management-led cluster
  • Derivative conversions could indicate future selling pressure if holders monetize positions
  • Biotech binary risk remains high regardless of insider activity

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ATTO-1786392765994
19 reports for ATTO
Performance horizon
83% Hit rate @ T+20 5 of 6 directional calls Went positive at some point 6 of 6 best @ T+20▲ +26.67%Aug 7, 2026
Filters
Rows
Reports for ATTO — sortable, filterable
TypeNow
Oct 8, 2026
18d ago
3/A
NEUTRAL ★ 1/10
$16.21awaiting T+20—$15.00 (−7.46%)
Oct 8, 2026
18d ago
3/A
NEUTRAL ★ 2/10
$16.21awaiting T+20—$15.00 (−7.46%)
Sep 28, 2026
29d ago
Press Release
NEUTRAL ★ 3/10
$18.16 $15.00▼ −17.40%▼ −18.12%$15.00 (−17.40%)
Sep 2, 2026
7w ago
Press Release
BULLISH ★ 7/10
$24.20 $17.14▼ −29.17%▼ −28.06%$15.00 (−38.02%)
Aug 28, 2026
8w ago
144 / CLUSTER
NEUTRAL ★ 3/10
$21.40 $18.16▼ −15.14%▼ −14.95%$15.00 (−29.91%)
Aug 13, 2026
10w ago
Insider Buy
BULLISH ★ 6/10
$19.86 $24.52▲ +23.46%▲ +25.46%$15.00 (−24.47%)
Aug 13, 2026
10w ago
Insider Cluster
BULLISH ★ 8/10
$19.86 $24.52▲ +23.46%▲ +25.46%$15.00 (−24.47%)
Aug 10, 2026
11w ago
Insider Cluster
BULLISH ★ 8/10
$18.65 $22.86▲ +22.57%▲ +23.63%$15.00 (−19.57%)
Aug 7, 2026
11w ago
Insider Cluster
NEUTRAL ★ 5/10
$19.84 $23.66▲ +19.25%▲ +20.17%$15.00 (−24.40%)
Aug 7, 2026
11w ago
Insider Cluster
BULLISH ★ 7/10
$20.17 $25.55▲ +26.67%▲ +27.07%$15.00 (−25.63%)
Showing 10 of 19

US Market Status

Market Closed — Opens Wed (15h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026